ArticleCureus2026
Cryoglobulinemic Vasculitis: Clinical Analysis of a Case and Its Diagnostic Relevance.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cryoglobulinemic vasculitis is an immune-complex-mediated small-vessel vasculitis characterized by complement activation and endothelial injury. Its clinical manifestations are heterogeneous and may range from limited cutaneous involvement to systemic disease. We report the case of a 65-year-old woman who developed a symmetrical violaceous dermatosis involving the upper and lower extremities, accompanied by arthralgias and distal paresthesias. Laboratory investigations revealed marked hypocomplementemia and positive circulating cryoglobulins. Histopathological examination of a skin biopsy demonstrated leukocytoclastic vasculitis, leading to the diagnosis of idiopathic cryoglobulinemic vasculitis after exclusion of hepatitis C virus infection, autoimmune diseases, and associated hematologic malignancies, with no evidence of major systemic organ involvement. Treatment with corticosteroid- and cyclophosphamide-based immunosuppression achieved sustained disease control, resulting in approximately 90% symptomatic improvement. This case highlights the importance of recognizing cardinal manifestations, such as palpable purpura, arthralgias, and hypocomplementemia, when evaluating patients with suspected cryoglobulinemic vasculitis, even in the absence of identifiable secondary causes. Early recognition, histopathological confirmation, and a multidisciplinary approach are essential for establishing an accurate diagnosis and implementing timely therapeutic intervention aimed at preventing disease progression and irreversible organ damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.